This sets out proposed new care models for glaucoma patients in order to better utilise primary care capacity, while still maintaining patient safety.
Glaucoma is the second leading cause of irreversible sight loss in the UK and affects over one million people, which is predicted to rise by 100,000 cases to 1.145 million people by 2030*.
In each issue, Acuity poses a topical question on a tricky scenario to a panel of members.
Clinical files: What impact should a patient's home genetics test have on my clinical decision-making?
Read the guidance on examining patients at risk from glaucoma
This member briefing covers the guideline on Glaucoma: diagnosis and management
Find out more about getting a College-accredited higher qualification in glaucoma.
More information for patients on glaucoma, including a directory to find their nearest optometrist member.
Adrian O’Dowd looks at why glaucoma is still undetected in some cases and how optometrists can sharpen up their practice.
Our Editor in Chief, Professor Leon Davies FCOptom, looks back at what's been another challenging year.
The clinical figures that count.
Heart attacks transiently increase in number when the clocks go forward. Diabetic retinopathy and glaucoma can interfere with the body’s sleep-wake cycles. Becky McCall examines the relationship between the eye and sleep.
Moorfields Eye Hospital NHS Foundation Trust and the UCL Institute of Ophthalmology has been accredited as a provider of the Professional Higher Certificate in Medical Retina by the College.
Contact lens technologies that can treat disease, and a possible link between caffeine intake and IOP.
With the Paralympics underway in Tokyo, Kathy Oxtoby reports on how patients with low vision can enjoy exercise and sport, and the benefits that go beyond keeping limber.
A glance at what’s happening in the world of technology.
Clinical editor Jane Veys considers the advantages of a blended healthcare approach.
Lockdowns led to cancelled operations and check-ups. Becky McCall looks at the legacy of the pandemic for eye disease and sight loss, and the lessons that have been learned.
What are the potential benefits of home glaucoma monitoring – and the challenges to be overcome? Juliette Astrup reports.